Healthcare Business Recap: Amgen’s FDA approval For Prolia, Vivus Expects Euro Rejection

Jim Cramer made the following calls on February 28th, 2013. What do you think about his picks? CommonWealth REIT (NYSE:CWH): Jim Cramer ranked this stock a Sell. The stock’s 52-week high is $25.25, and its 52-week low is $13.46. Apple's stock has been br

Fulton Financial (FULT) was downgraded from buy to neutral, Sterne Agee said. Valuation call. Intuitive Surgical (ISRG) was upgraded from hold to buy, Cantor Fitzgerald said. $575 price target. Stock has overreacted to news of the FDA probe. Micros (MCRS

Andrew Mason has been removed as Groupon's (GRPN) CEO, effectively immediately, and is being replaced by Executive Chairman Eric Lefkofsky and Vice Chairman Ted Leonsis in the interim. Lefokofsky and Leonsis will be part of the newly created Office of th

Before I get to the reader email and Tweets, I want to invite everyone to hang out with me on Monday, March 4, when I live-blog the Depomed (DEPO) FDA advisory panel reviewing Sefelsa as a new treatment for post-menopausal hot flashes. Joining me on the

Rounding out the list of winners, Disney (DIS) and General Electric (GE), another Action Alerts PLUS name. Disney has gained from great acquisitions like Marvel and Star Wars, while GE gets its strength from its exposure to everything from infrastructure

Sometimes a pullback is a caution sign. And other times it's an opportunity. In this case, Jim Cramer thinks it's the latter. "Sometimes you need to wait for a stock to stumble in order to get a chance to buy it at a decent price," Cramer said. (Having t